Sanofi Soci News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Janssen to Highlight Latest Research on Multiple Sclerosis at ACTRIMS Forum 2021
News provided by
Share this article
Share this article
TITUSVILLE, N.J., Feb. 24, 2021 /PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that its latest multiple sclerosis (MS) research will be presented at the 2021 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum from February 25-27. Nine Janssen-sponsored data abstracts on MS research will be presented, including real-world evidence highlighting the impact of fatigue in U.S. adults with relapsing MS (RMS); a study assessing the impact of MS fatigue on work productivity and activity impairment; and cross-sectional analyses of both the economic and humanistic burden associated with fatigue in relapsing-remitting MS. ....

United States , Jennifer Mcintyre , Chris Delorefice , Bill Martin , Us National Health , Americas Committee For Treatment , Sclerosis Association Of America , National Multiple Sclerosis Society , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Research In Multiple Sclerosis , None Of The Janssen Pharmaceutical Companies , Drug Administration , Actelion Pharmaceuticals Ltd , Exchange Commission , Companies Of Johnson , Idorsia Pharmaceuticals Ltd , European Medicines Agency , Multiple Sclerosis , Global Therapeutic Area Head , Janssen Research , Data Presentations Include , Fatigue Status , Disease Activity , Fatigue Symptom ,